Acquired von Willebrand syndrome: an important bleeding complication to be considered in patients with lymphoproliferative and myeloproliferative disorders.
Federici
A B
AB
Angelo Bianchi Bonomi Hemophilia Thrombosis Center, Department of Internal Medicine, IRCCS Maggiore Hospital and University of Milan, Milan, Italy. Augusto.Federici@unimi.it
Rand
J H
JH
Mannucci
P M
PM
D005260:Female; D006470:Hemorrhage / Q000188:drug therapy / Q000209:etiology; D006490:Hemostatics / Q000627:therapeutic use; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D008297:Male; D009196:Myeloproliferative Disorders / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D014842:von Willebrand Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology
D006490:Hemostatics